Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries

Authors: Patricia P Gomez, Julie Gutman, Elaine Roman, Aimee Dickerson, Zandra H Andre, Susan Youll, Erin Eckert, Mary J Hamel

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

At least 39 sub-Saharan African countries have policies on preventing malaria in pregnancy (MIP), including use of long-lasting insecticidal nets (LLINs), intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) and case management. However, coverage of LLINs and IPTp-SP remains below international targets in most countries. One factor contributing to low coverage may be that MIP policies typically are developed by national malaria control programmes (NMCPs), but are implemented through national reproductive health (RH) programmes.

Methods

National-level MIP policies, guidelines, and training documents from NMCPs and RH programmes in Kenya, Mali, Mozambique, mainland Tanzania and Uganda were reviewed to assess whether they reflected WHO guidelines for prevention and treatment of MIP, and how consistent MIP content was across documents from the same country. Documents were compared for adherence to WHO guidance concerning IPTp-SP timing and dose, directly observed therapy, promotion and distribution of LLINs, linkages to HIV programmes and MIP case management.

Results

The five countries reviewed had national documents promoting IPTp-SP, LLINs and MIP case management. WHO guidance from 2004 frequently was not reflected: four countries recommended the first dose of IPTp-SP at 20 weeks or later (instead of 16 weeks), and three countries restricted the first and second IPTp-SP doses to specific gestational weeks. Documents from four countries provided conflicting guidance on MIP prevention for HIV-positive women, and none provided complete guidance on management of uncomplicated and severe malaria during pregnancy. In all countries, inconsistencies between NMCPs and RH programmes on the timing or dose of IPTp-SP were documented, as was the mechanism for providing LLINs. Inconsistencies also were found in training documents from NMCPs and RH programmes in a given country. Outdated, inconsistent guidelines have the potential to cause confusion and lead to incorrect practices among health workers who implement MIP programmes, contributing to low coverage of IPTp-SP and LLINs.

Conclusions

MIP policies, guidelines and training materials are outdated and/or inconsistent in the countries assessed. Updating and ensuring consistency among national MIP documents is needed, along with re-orientation and supervision of health workers to accelerate implementation of the 2012 WHO Global Malaria Programme policy recommendations for IPTp-SP.
Literature
1.
go back to reference Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.CrossRefPubMed Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.CrossRefPubMed
2.
go back to reference Global Malaria Programme WHO: Insecticide-treated Mosquito Nets: a WHO Position Statement. 2007, Geneva: World Health Organization Global Malaria Programme WHO: Insecticide-treated Mosquito Nets: a WHO Position Statement. 2007, Geneva: World Health Organization
4.
go back to reference WHO: T3: Test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. 2012, Geneva: World Health Organization WHO: T3: Test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. 2012, Geneva: World Health Organization
6.
go back to reference Manyando C, Njunju EM, D’Alessandro U, Van Geertruyden JP: Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One. 2013, 8: e56916-10.1371/journal.pone.0056916.PubMedCentralCrossRefPubMed Manyando C, Njunju EM, D’Alessandro U, Van Geertruyden JP: Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One. 2013, 8: e56916-10.1371/journal.pone.0056916.PubMedCentralCrossRefPubMed
9.
go back to reference van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, ter Kuile FO: Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Inf Dis. 2013, 13: 102942-CrossRef van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, ter Kuile FO: Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Inf Dis. 2013, 13: 102942-CrossRef
10.
go back to reference Gross K, Alba S, Schellenberg J, Kessy F, Mayumana I, Obrist B: The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley. Tanzania Malar J. 2011, 10: 140-CrossRefPubMed Gross K, Alba S, Schellenberg J, Kessy F, Mayumana I, Obrist B: The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley. Tanzania Malar J. 2011, 10: 140-CrossRefPubMed
11.
go back to reference Hill J, Hoyt J, van Eijk AM, D’Mello-Guyett L, ter Kuile FO, Steketee R, Smith H, Webster J: Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013, 10: e1001488-10.1371/journal.pmed.1001488. doi: 10.1371/journal.pmed.1001488PubMedCentralCrossRefPubMed Hill J, Hoyt J, van Eijk AM, D’Mello-Guyett L, ter Kuile FO, Steketee R, Smith H, Webster J: Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013, 10: e1001488-10.1371/journal.pmed.1001488. doi: 10.1371/journal.pmed.1001488PubMedCentralCrossRefPubMed
12.
go back to reference Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, Otieno P, Ombock M, Kariuki S, Desai M, Hamel MJ, tr Kuile FO, Webster J: Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya. PLoS One. 2013, 8: e64913-10.1371/journal.pone.0064913. doi: 10.1371/journal.pone.0064913PubMedCentralCrossRefPubMed Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, Otieno P, Ombock M, Kariuki S, Desai M, Hamel MJ, tr Kuile FO, Webster J: Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya. PLoS One. 2013, 8: e64913-10.1371/journal.pone.0064913. doi: 10.1371/journal.pone.0064913PubMedCentralCrossRefPubMed
13.
go back to reference WHO Regional Office for Africa: A strategic framework for malaria prevention and control during pregnancy in the Africa region. 2004, Brazzaville: World Health Organization WHO Regional Office for Africa: A strategic framework for malaria prevention and control during pregnancy in the Africa region. 2004, Brazzaville: World Health Organization
14.
go back to reference WHO: Guidelines for the Treatment of Malaria. 2010, Geneva: World Health Organization, 2 WHO: Guidelines for the Treatment of Malaria. 2010, Geneva: World Health Organization, 2
15.
go back to reference Global Malaria Programme WHO: Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). 2013, Geneva: World Health Organization Global Malaria Programme WHO: Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). 2013, Geneva: World Health Organization
16.
go back to reference Stoltzfus RJ, Dreyfuss ML: Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. 1998, Washington, DC: ILSI Press Stoltzfus RJ, Dreyfuss ML: Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. 1998, Washington, DC: ILSI Press
17.
go back to reference ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. JAMA. 2007, 297: 2603-2616. 10.1001/jama.297.23.2603.CrossRefPubMed ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. JAMA. 2007, 297: 2603-2616. 10.1001/jama.297.23.2603.CrossRefPubMed
18.
go back to reference WHO HIV/AIDS Programme: Programmatic Update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. 2012, Geneva: World Health Organization WHO HIV/AIDS Programme: Programmatic Update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. 2012, Geneva: World Health Organization
19.
go back to reference WHO: Accelerating Malaria in Pregnancy Programming in Zambia: A Malaria in Pregnancy Case Study. 2012, Geneva: World Health Organization WHO: Accelerating Malaria in Pregnancy Programming in Zambia: A Malaria in Pregnancy Case Study. 2012, Geneva: World Health Organization
Metadata
Title
Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries
Authors
Patricia P Gomez
Julie Gutman
Elaine Roman
Aimee Dickerson
Zandra H Andre
Susan Youll
Erin Eckert
Mary J Hamel
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-212

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.